Diovan and Pancreatitis relapsing - a phase IV clinical study of FDA data

Summary:

Pancreatitis relapsing is reported as a side effect among people who take Diovan (valsartan), especially for people who are female, 50-59 old, also take Topamax, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Pancreatitis relapsing when taking Diovan. It is created by eHealthMe based on reports of 80,750 people who have side effects when taking Diovan from the FDA, and is updated regularly.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,153 Diovan users. Check the latest studies of Diovan.

What is Pancreatitis relapsing?

Pancreatitis relapsing is found to be associated with 176 drugs and 299 conditions by eHealthMe. Check the latest studies of Pancreatitis relapsing.

On Jul, 31, 2026

80,750 people reported to have side effects when taking Diovan.
Among them, 20 people (0.02%) have Pancreatitis relapsing.

Could Diovan cause Pancreatitis relapsing?

Among these 20 people:

What is the gender of people who have Pancreatitis relapsing when taking Diovan? *

female: 75 %
male: 25 %

What is the age of people who have Pancreatitis relapsing when taking Diovan? *

What are other drugs people take besides Diovan? *

What are other side effects people have besides Pancreatitis relapsing? *

Diabetes: 11 people, 55.00%
Kidney Stones: 11 people, 55.00%
Heart Attack: 11 people, 55.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 11 people, 55.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 11 people, 55.00%
Back Pain: 11 people, 55.00%
Hypomania (a mild form of mania, marked by elation and hyperactivity): 11 people, 55.00%
Muscle Function Loss: 10 people, 50.00%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 10 people, 50.00%
Oedema (fluid collection in tissue): 10 people, 50.00%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 12 people, 60.00%
Quit Smoking: 11 people, 55.00%
Heart Attack: 11 people, 55.00%
Diabetes: 4 people, 20.00%
Type 2 Diabetes: 3 people, 15.00%
Neuropathy Peripheral (surface nerve damage): 3 people, 15.00%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 5.00%
Stress And Anxiety: 1 person, 5.00%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 5.00%
Hepatitis C: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Diovan and have Pancreatitis relapsing?

- Check whether Pancreatitis relapsing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diovan:

Diovan (83,153 reports)

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis relapsing:

Pancreatitis relapsing (176 drugs)

Browse all the conditions that are associated with Pancreatitis relapsing:

Pancreatitis relapsing (299 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Diovan) and Diovan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.